Development of Dual-Pore Coexisting Branched Silica Nanoparticles for Efficient Gene-Chemo Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Combination therapy is crucial for overcoming cancer treatment limitations.
• Simultaneous delivery of multiple therapeutic agents offers synergistic effects but faces challenges in nanomaterial design.
• Developing effective nanocarriers for co-delivery of genes and drugs is a significant research area.

Purpose of the Study:

• To develop dual-pore coexisting hybrid porous silica nanoparticles for efficient co-delivery of genes and anticancer drugs.
• To demonstrate the controlled loading and release capabilities of the designed nanoparticles.
• To evaluate the efficacy of the gene-chemo combination therapy using these nanoparticles.

Main Methods:

• Fabrication of hybrid porous silica nanoparticles via Volmer-Weber growth pathway.
• Utilizing distinct pore sizes (2-3 nm and 40-45 nm) and surface modifications for differential loading.
• In vitro evaluation of loading capacity, controlled release, cytotoxicity, and therapeutic efficiency against human cervical cancer cells.

Main Results:

• Successfully developed hybrid porous silica nanoparticles with dual-pore architecture.
• Achieved efficient co-loading and controlled release of gene and anticancer drug payloads.
• Demonstrated excellent loading capacity and low cytotoxicity of the nanoparticle platform.
• Validated significant gene-chemo combinational therapeutic efficiency against human cervical cancer cells.

Conclusions:

• The developed dual-pore hybrid porous silica nanoparticles enable efficient co-delivery of genes and anticancer drugs.
• This platform exhibits excellent loading capacity, controlled release, and low cytotoxicity.
• The nanoparticles show significant potential for combination cancer therapy and broader biomedical applications requiring co-delivery.